Ann: ResApp announces positive results of COVID-19 screening test, page-294

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 294 Last

Share
Profile

Follow
Sonny87

46 Posts.

137

23/03/22

11:22

Post #: 60363448
Share
Originally posted by ashtool: ↑

How is the app going to work for the very many (in some age brackets, the majority) who are asymptomatic and have no cough? It won't, thus people will still need RATs and PCRs.
How can an 80% clinical specificity (ie: 1/5 who are true 'positive' get a false-negative and re-enter the community) be reliable at all? I would be surprised if this underwhelming result even passes the TGA standard when it comes to it.
How does RAP substantiate its claim of "92% sensitivity for detecting COVID-19 with a new cough audio-based algorithm –exceeding the real-world measured sensitivity of rapid antigen testing" when the majority of new RATs being approved by the TGA have > 95% clinical sensitivity and > 98% clinical specificity?

Source: https://www.tga.gov.au/covid-19-rapid-antigen-self-tests-are-approved-australia

Table showing latest TGA approved RATs in Australia for home-use:

Clinical data or product:
This is just one example. Click on any of the "Very High sensitivity" TGA approved products, and all of them leave RAP's results for dead.

These are important questions to ask, given a CR likely approaching.

Expand

Hi Ashtool. Great to see you've heard the news. If you are genuinely interested in understanding the results and their real world application please watch the investor conference call. Their is a great explanation by Professor Catherine Bennett, Deakin’s Chair in Epidemiology within Deakin’s Institute for Health Transformation and member of Resapp's COVID-19 Scientific Advisory Board.
RAP Price at posting: 7.8¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions

Reporting wrap: Inghams, Accent, Mayne Pharma

The business of sport: Warren Tredrea's take on this week's news

NRX

Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt

SER

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

IPH

IPH raises $100M to buy up Canadian IP firm Bereskin & Parr

The Rising Tide: How institutional adoption is shaping the future of crypto

RDN

Raiden gears up for exploration in final quarter of 2024

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back

There are more pages in this discussion • 237 more messages in this thread...

First 294 Last

Add RAP (ASX) to my watchlist

Ann: ResApp announces positive results of COVID-19 screening test, page-294

Top Stories

Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions

Reporting wrap: Inghams, Accent, Mayne Pharma

The business of sport: Warren Tredrea's take on this week's news

Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

IPH raises $100M to buy up Canadian IP firm Bereskin & Parr

The Rising Tide: How institutional adoption is shaping the future of crypto

Raiden gears up for exploration in final quarter of 2024

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back

Featured News